Exercise training for adults undergoing maintenance dialysis

Amelie Bernier-Jean, Nadim A Beruni, Nicola P Bondonno, Gabrielle Williams, Armando Teixeira-Pinto, Jonathan C Craig, Germaine Wong, Amelie Bernier-Jean, Nadim A Beruni, Nicola P Bondonno, Gabrielle Williams, Armando Teixeira-Pinto, Jonathan C Craig, Germaine Wong

Abstract

Background: Dialysis treatments weigh heavily on patients' physical and psychosocial health. Multiple studies have assessed the potential for exercise training to improve outcomes in adults undergoing dialysis. However, uncertainties exist in its relevance and sustainable benefits for patient-important outcomes. This is an update of a review first published in 2011.

Objectives: To assess the benefits and safety of regular structured exercise training in adults undergoing dialysis on patient-important outcomes including death, cardiovascular events, fatigue, functional capacity, pain, and depression. We also aimed to define the optimal prescription of exercise in adults undergoing dialysis.

Search methods: In this update, we conducted a systematic search of the Cochrane Kidney and Transplant Register of Studies up to 23 December 2020. The Register includes studies identified from CENTRAL, MEDLINE, EMBASE, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov as well as kidney-related journals and the proceedings of major kidney conferences.

Selection criteria: Randomised controlled trials (RCTs) and quasi-RCTs of any structured exercise programs of eight weeks or more in adults undergoing maintenance dialysis compared to no exercise or sham exercise.

Data collection and analysis: Two authors independently assessed the search results for eligibility, extracted the data and assessed the risk of bias using the Cochrane risk of bias tool. Whenever appropriate, we performed random-effects meta-analyses of the mean difference in outcomes. The primary outcomes were death (any cause), cardiovascular events and fatigue. Secondary outcomes were health-related quality of life (HRQoL), depression, pain, functional capacity, blood pressure, adherence to the exercise program, and intervention-related adverse events.

Main results: We identified 89 studies involving 4291 randomised participants, of which 77 studies (3846 participants) contributed to the meta-analyses. Seven studies included adults undergoing peritoneal dialysis. Fifty-six studies reported aerobic exercise interventions, 21 resistance exercise interventions and 19 combined aerobic and resistance training within the same study arm. The interventions lasted from eight weeks to two years and most often took place thrice weekly during dialysis treatments. A single study reported death and no study reported long-term cardiovascular events. Five studies directly assessed fatigue, 46 reported HRQoL and 16 reported fatigue or pain through their assessment of HRQoL. Thirty-five studies assessed functional capacity, and 21 reported resting peripheral blood pressure. Twelve studies reported adherence to exercise sessions, and nine reported exercise-related adverse events. Overall, the quality of the included studies was low and blinding of the participants was generally not feasible due to the nature of the intervention. Exercise had uncertain effects on death, cardiovascular events, and the mental component of HRQoL due to the very low certainty of evidence. Compared with sham or no exercise, exercise training for two to 12 months may improve fatigue in adults undergoing dialysis, however, a meta-analysis could not be conducted. Any exercise training for two to 12 months may improve the physical component of HRQoL (17 studies, 656 participants: MD 4.12, 95% CI 1.88 to 6.37 points on 100 points-scale; I² = 49%; low certainty evidence). Any exercise training for two to 12 months probably improves depressive symptoms (10 studies, 441 participants: SMD -0.65, 95% CI -1.07 to -0.22; I² = 77%; moderate certainty evidence) and the magnitude of the effect may be greater when maintaining the exercise beyond four months (6 studies, 311 participants: SMD -0.30, 95% CI 0.14 to -0.74; I² = 71%). Any exercise training for three to 12 months may improve pain (15 studies, 872 participants: MD 5.28 95% CI -0.12 to 10.69 points on 100 points-scale; I² = 63%: low certainty evidence) however, the 95% CI indicates that exercise training may make little or no difference in the level of pain. Any exercise training for two to six months probably improves functional capacity as it increased the distance reached during six minutes of walking (19 studies, 827 participants: MD 49.91 metres, 95% CI 37.22 to 62.59; I² = 34%; moderate certainty evidence) and the number of sit-to-stand cycles performed in 30 seconds (MD 2.33 cycles, 95% CI 1.71 to 2.96; moderate certainty evidence). There was insufficient evidence to assess the safety of exercise training for adults undergoing maintenance dialysis. The results were similar for aerobic exercise, resistance exercise, and a combination of both aerobic and resistance exercise.

Authors' conclusions: It is uncertain whether exercise training improves death, cardiovascular events, or the mental component of HRQoL in adults undergoing maintenance dialysis. Exercise training probably improves depressive symptoms, particularly when the intervention is maintained beyond four months. Exercise training is also likely to improve functional capacity. Low certainty evidence suggested that exercise training may improve fatigue, the physical component of quality of life, and pain. The safety of exercise training for adults undergoing dialysis remains uncertain.

Trial registration: ClinicalTrials.gov NCT02718638 NCT01813851 NCT03027778 NCT02234232 NCT00179140 NCT01255969 NCT02834026 NCT00942253 NCT01234441 NCT00250536 NCT00944775 NCT02651025 NCT02697942 NCT02874521 NCT01234688 NCT02621918 NCT02623348 NCT03334123 NCT00492362 NCT03041155 NCT02753868 NCT01481688 NCT03905551 NCT01674153 NCT02075879 NCT03616535 NCT02222402 NCT01990495 NCT01721551.

Conflict of interest statement

  1. Amelie Bernier‐Jean has declared that they have no conflict of interest

  2. Nadim A Beruni has declared that they have no conflict of interest

  3. Nicola Patricia P Bondonno has declared that they have no conflict of interest

  4. Gabrielle Williams has declared that they have no conflict of interest

  5. Armando Teixeira‐Pinto has declared that they have no conflict of interest

  6. Jonathan C Craig has declared that they have no conflict of interest

  7. Germaine Wong has declared that they have no conflict of interest

Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Figures

1
1
Flow diagram showing study identification and selection
2
2
Methodological quality graph: review authors' judgements about each methodological quality item presented as percentages across all included studies.
1.1. Analysis
1.1. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 1: Death
1.2. Analysis
1.2. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 2: Fatigue
1.3. Analysis
1.3. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 3: HRQoL: Summary component scores
1.4. Analysis
1.4. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 4: HRQoL: Individual domains
1.5. Analysis
1.5. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 5: Depression
1.6. Analysis
1.6. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 6: 6MWT
1.7. Analysis
1.7. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 7: Sit‐To‐Stand test [N reps/30 sec]
1.8. Analysis
1.8. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 8: Sit‐To‐Stand test [sit to 5 reps]
1.9. Analysis
1.9. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 9: Systolic blood pressure
1.10. Analysis
1.10. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 10: Diastolic blood pressure
1.11. Analysis
1.11. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 11: Aerobic capacity (VO max or peak)
1.12. Analysis
1.12. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 12: Albumin
1.13. Analysis
1.13. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 13: Blood lipids
1.14. Analysis
1.14. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 14: Body composition
1.15. Analysis
1.15. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 15: Body mass index
1.16. Analysis
1.16. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 16: Calcium
1.17. Analysis
1.17. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 17: C‐reactive protein
1.18. Analysis
1.18. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 18: Dialysis adequacy: Kt/V
1.19. Analysis
1.19. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 19: Energy intake
1.20. Analysis
1.20. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 20: Haemoglobin
1.21. Analysis
1.21. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 21: Left ventricular ejection fraction
1.22. Analysis
1.22. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 22: Left ventricular mass index
1.23. Analysis
1.23. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 23: Maximum heart rate
1.24. Analysis
1.24. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 24: Muscular strength
1.25. Analysis
1.25. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 25: Phosphate
1.26. Analysis
1.26. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 26: Potassium
1.27. Analysis
1.27. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 27: Protein intake
1.28. Analysis
1.28. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 28: Parathyroid hormone
1.29. Analysis
1.29. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 29: Resting heart rate
1.30. Analysis
1.30. Analysis
Comparison 1: Any exercise versus control (no exercise/placebo exercise), Outcome 30: Timed up‐and‐go test
2.1. Analysis
2.1. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 1: Death
2.2. Analysis
2.2. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 2: Fatigue
2.3. Analysis
2.3. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 3: HRQoL: Summary component scores
2.4. Analysis
2.4. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 4: HRQoL: Individual domains
2.5. Analysis
2.5. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 5: Depression
2.6. Analysis
2.6. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 6: 6MWT
2.7. Analysis
2.7. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 7: Sit‐To‐Stand test [N reps/30 sec]
2.8. Analysis
2.8. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 8: Sit‐To‐Stand test [sit to 5 reps]
2.9. Analysis
2.9. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 9: Resting blood pressure
2.10. Analysis
2.10. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 10: Aerobic capacity (VO2 max or peak)
2.11. Analysis
2.11. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 11: Albumin
2.12. Analysis
2.12. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 12: Blood lipids
2.13. Analysis
2.13. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 13: Body composition
2.14. Analysis
2.14. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 14: Body mass index
2.15. Analysis
2.15. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 15: Calcium
2.16. Analysis
2.16. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 16: C‐reactive protein
2.17. Analysis
2.17. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 17: Dialysis adequacy: Kt/V
2.18. Analysis
2.18. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 18: Energy intake
2.19. Analysis
2.19. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 19: Haemoglobin
2.20. Analysis
2.20. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 20: Heart rate
2.21. Analysis
2.21. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 21: Left ventricular ejection fraction
2.22. Analysis
2.22. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 22: Left ventricular mass index
2.23. Analysis
2.23. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 23: Muscular strength
2.24. Analysis
2.24. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 24: Phosphate
2.25. Analysis
2.25. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 25: Potassium
2.26. Analysis
2.26. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 26: Protein intake
2.27. Analysis
2.27. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 27: Parathyroid hormone
2.28. Analysis
2.28. Analysis
Comparison 2: Aerobic exercise versus control (no exercise/placebo exercise), Outcome 28: Timed up‐and‐go test
3.1. Analysis
3.1. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 1: Fatigue
3.2. Analysis
3.2. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 2: HRQoL: Summary component scores
3.3. Analysis
3.3. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 3: HR‐QoL: Individual domains
3.4. Analysis
3.4. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 4: Depression
3.5. Analysis
3.5. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 5: 6MWT
3.6. Analysis
3.6. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 6: Sit‐To‐Stand test [N reps/30 sec]
3.7. Analysis
3.7. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 7: Sit‐To‐Stand test [N reps/30 sec]
3.8. Analysis
3.8. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 8: Albumin
3.9. Analysis
3.9. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 9: Blood lipids
3.10. Analysis
3.10. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 10: Body composition
3.11. Analysis
3.11. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 11: Body mass index
3.12. Analysis
3.12. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 12: Calcium
3.13. Analysis
3.13. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 13: CRP
3.14. Analysis
3.14. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 14: Dialysis adequacy: Kt/V
3.15. Analysis
3.15. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 15: Energy intake
3.16. Analysis
3.16. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 16: Haemoglobin
3.17. Analysis
3.17. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 17: Muscular strength
3.18. Analysis
3.18. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 18: Phosphate
3.19. Analysis
3.19. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 19: Potassium
3.20. Analysis
3.20. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 20: Protein intake
3.21. Analysis
3.21. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 21: PTH
3.22. Analysis
3.22. Analysis
Comparison 3: Resistance exercise versus control (no exercise/placebo exercise), Outcome 22: Timed up‐and‐go test
4.1. Analysis
4.1. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 1: HRQoL: Summary component scores
4.2. Analysis
4.2. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 2: HRQoL: Individual domains
4.3. Analysis
4.3. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 3: Depression
4.4. Analysis
4.4. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 4: 6MWT
4.5. Analysis
4.5. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 5: Sit‐To‐Stand test [N reps/30 sec]
4.6. Analysis
4.6. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 6: Sit‐To‐Stand test [sit to 5 reps]
4.7. Analysis
4.7. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 7: Resting blood pressure
4.8. Analysis
4.8. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 8: Aerobic capacity (VO2 max or peak)
4.9. Analysis
4.9. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 9: Albumin
4.10. Analysis
4.10. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 10: Blood lipids
4.11. Analysis
4.11. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 11: Body composition
4.12. Analysis
4.12. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 12: Body mass index
4.13. Analysis
4.13. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 13: Calcium
4.14. Analysis
4.14. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 14: CRP
4.15. Analysis
4.15. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 15: Dialysis adequacy: Kt/V
4.16. Analysis
4.16. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 16: Energy intake
4.17. Analysis
4.17. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 17: Haemoglobin
4.18. Analysis
4.18. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 18: Heart rate
4.19. Analysis
4.19. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 19: Muscular strength
4.20. Analysis
4.20. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 20: Phosphate
4.21. Analysis
4.21. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 21: Potassium
4.22. Analysis
4.22. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 22: Protein intake
4.23. Analysis
4.23. Analysis
Comparison 4: Combined aerobic and resistance exercise versus control (no exercise/placebo exercise), Outcome 23: Timed up‐and‐go test

Source: PubMed

3
Subscribe